The global Next Generation Sequencing (NGS) Market size was estimated at USD 12,990 million in 2024 and is projected to reach USD 31,910.4 million in 2031 at a CAGR of 13.7 % during the forecast period 2025-2031.
Next Generation Sequencing (NGS) refers to a set of advanced technologies that allow for rapid and high-throughput sequencing of DNA and RNA, enabling researchers to decode genetic material more efficiently and cost-effectively than traditional methods. NGS encompasses various techniques that facilitate deep sequencing, such as whole genome sequencing, exome sequencing, and transcriptome sequencing, allowing for detailed analyses of genetic variations, mutations, and gene expression profiles. This technology has revolutionized genomic research, clinical diagnostics, and personalized medicine, offering a powerful tool for understanding complex biological processes and diseases.